OCA at 10:28, 22 November 2023

2023-11-22T10:28:21Z

←Older revision		Revision as of 10:28, 22 November 2023
Line 1:		Line 1:

	==Human LXR-beta in complex with an agonist==		==Human LXR-beta in complex with an agonist==
-	<StructureSection load='6k9h' size='340' side='right'caption='[[6k9h]]' scene=''>	+	<StructureSection load='6k9h' size='340' side='right'caption='[[6k9h]], [[Resolution\|resolution]] 2.50Å' scene=''>
	== Structural highlights ==		== Structural highlights ==
-	<table><tr><td colspan='2'>Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6K9H OCA]. For a <b>guided tour on the structure components</b> use [~~http~~://proteopedia.org/fgij/fg.htm?mol=6K9H FirstGlance]. <br>	+	<table><tr><td colspan='2'>[[6k9h]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6K9H OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=6K9H FirstGlance]. <br>
-	</td></tr><tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[~~http~~://proteopedia.org/fgij/fg.htm?mol=6k9h FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6k9h OCA], [~~http~~://pdbe.org/6k9h PDBe], [~~http~~://www.rcsb.org/pdb/explore.do?structureId=6k9h RCSB], [~~http~~://www.ebi.ac.uk/pdbsum/6k9h PDBsum], [~~http~~://prosat.h-its.org/prosat/prosatexe?pdbcode=6k9h ProSAT]</span></td></tr>	+	</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models\|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution\|Resolution]] 2.5Å</td></tr>
		+	<tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=D40:~{tert}-butyl+(2~{S},3~{S})-2-oxidanylidene-2-phenyl-spiro[1~{H}-indole-3,3-pyrrolidine]-1-carboxylate'>D40</scene></td></tr>
		+	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=6k9h FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6k9h OCA], [https://pdbe.org/6k9h PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=6k9h RCSB], [https://www.ebi.ac.uk/pdbsum/6k9h PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=6k9h ProSAT]</span></td></tr>
	</table>		</table>
		+	== Function ==
		+	[https://www.uniprot.org/uniprot/NR1H2_HUMAN NR1H2_HUMAN] Orphan receptor. Binds preferentially to double-stranded oligonucleotide direct repeats having the consensus half-site sequence 5'-AGGTCA-3' and 4-nt spacing (DR-4). Regulates cholesterol uptake through MYLIP-dependent ubiquitination of LDLR, VLDLR and LRP8 (By similarity).
		+	<div style="background-color:#fffaf0;">
		+	== Publication Abstract from PubMed ==
		+	Discovery and optimization of selective liver X receptor beta (LXRbeta) agonists are challenging due to the high homology of LXRalpha and LXRbeta in the ligand-binding domain. There is only one different residue (Val versus Ile) at the ligand-binding pocket of LXRs. With machine learning methods, we identified pan LXR agonists with a novel scaffold (spiro[pyrrolidine-3,3'-oxindole]). Then, we figured out the mechanism of LXR isoform selectivity from co-crystal structures. Based on the mechanism and the new scaffold, LXRbeta selective agonists were designed and synthesized. This led to the discovery of LXRbeta agonists 4-7rr, 4-13 and 4-13rr with IC50 values ranging from 1.78 to 6.36 muM against glioblastoma in vitro. Treatment with 50 mg/kg/day of 4-13 for 15 days significantly reduced tumor growth using an in vivo xenograft glioblastoma model.
		+
		+	Discovery of new LXRbeta agonists as glioblastoma inhibitors.,Chen H, Chen Z, Zhang Z, Li Y, Zhang S, Jiang F, Wei J, Ding P, Zhou H, Gu Q, Xu J Eur J Med Chem. 2020 May 15;194:112240. doi: 10.1016/j.ejmech.2020.112240. Epub, 2020 Mar 17. PMID:32248003<ref>PMID:32248003</ref>
		+
		+	From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br>
		+	</div>
		+	<div class="pdbe-citations 6k9h" style="background-color:#fffaf0;"></div>
		+
		+	==See Also==
		+	*[[Liver X receptor\|Liver X receptor]]
		+	== References ==
		+	<references/>
	__TOC__		__TOC__
	</StructureSection>		</StructureSection>
		+	[[Category: Homo sapiens]]
	[[Category: Large Structures]]		[[Category: Large Structures]]
	[[Category: Zhang Z]]		[[Category: Zhang Z]]
	[[Category: Zhou H]]		[[Category: Zhou H]]

OCA at 05:39, 22 April 2020

2020-04-22T05:39:59Z

←Older revision		Revision as of 05:39, 22 April 2020
Line 1:		Line 1:
-	'''Unreleased structure'''

-	~~The entry~~ 6k9h ~~is ON HOLD until Paper Publication~~	+	==Human LXR-beta in complex with an agonist==
-		+	<StructureSection load='6k9h' size='340' side='right'caption='[[6k9h]]' scene=''>
-	~~Authors~~: ~~Zhang~~, Z., ~~Zhou~~, H.	+	== Structural highlights ==
-		+	<table><tr><td colspan='2'>Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6K9H OCA]. For a <b>guided tour on the structure components</b> use [http://proteopedia.org/fgij/fg.htm?mol=6K9H FirstGlance]. <br>
-	~~Description~~: ~~Human LXR~~-~~beta in complex with an agonist~~	+	</td></tr><tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://proteopedia.org/fgij/fg.htm?mol=6k9h FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6k9h OCA], [http://pdbe.org/6k9h PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=6k9h RCSB], [http://www.ebi.ac.uk/pdbsum/6k9h PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=6k9h ProSAT]</span></td></tr>
-	[[Category: ~~Unreleased~~ Structures]]	+	</table>
-	[[Category: ~~Zhou, H~~]]	+	__TOC__
-	[[Category: ~~Zhang, Z~~]]	+	</StructureSection>
		+	[[Category: Large Structures]]
		+	[[Category: Zhang Z]]
		+	[[Category: Zhou H]]

OCA: Protected "6k9h" [edit=sysop:move=sysop]

2019-06-26T05:05:34Z

Protected "6k9h" [edit=sysop:move=sysop]

←Older revision

Revision as of 05:05, 26 June 2019

OCA: New page: '''Unreleased structure''' The entry 6k9h is ON HOLD until Paper Publication Authors: Zhang, Z., Zhou, H. Description: Human LXR-beta in complex with an agonist [[Category: Unreleased ...

2019-06-26T05:05:33Z

New page: '''Unreleased structure''' The entry 6k9h is ON HOLD until Paper Publication Authors: Zhang, Z., Zhou, H. Description: Human LXR-beta in complex with an agonist [[Category: Unreleased ...

New page

'''Unreleased structure'''

The entry 6k9h is ON HOLD until Paper Publication

Authors: Zhang, Z., Zhou, H.

Description: Human LXR-beta in complex with an agonist
[[Category: Unreleased Structures]]
[[Category: Zhou, H]]
[[Category: Zhang, Z]]

6k9h - Revision history

OCA at 10:28, 22 November 2023

OCA at 05:39, 22 April 2020

OCA: Protected "6k9h" [edit=sysop:move=sysop]

OCA: New page: '''Unreleased structure''' The entry 6k9h is ON HOLD until Paper Publication Authors: Zhang, Z., Zhou, H. Description: Human LXR-beta in complex with an agonist [[Category: Unreleased ...